Improving breast cancer treatment in Nigeria
Improving Adherence to Breast Cancer Treatment Guidelines in Nigeria
This study is working to make breast cancer care better in Nigeria by helping doctors follow important treatment guidelines, so that women with breast cancer can get the best care possible, even in places with fewer resources.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10917147 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of breast cancer care in Nigeria by improving healthcare providers' adherence to established clinical practice guidelines. It aims to develop and evaluate strategies that ensure effective treatment is accessible to patients, particularly in resource-limited settings. The project will assess the implementation of the National Comprehensive Cancer Network (NCCN) Harmonized Guidelines, which are designed to provide evidence-based care tailored to the local context. By addressing barriers to guideline adherence, the research seeks to improve patient outcomes and survival rates for women with breast cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with breast cancer in Nigeria who are seeking effective treatment options.
Not a fit: Patients outside of Nigeria or those with breast cancer who are already receiving guideline-concordant care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better breast cancer treatment outcomes for women in Nigeria by ensuring they receive guideline-concordant care.
How similar studies have performed: Previous research has shown that implementing structured guidelines can significantly improve treatment outcomes in similar healthcare settings.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Romanoff, Anya — Icahn School of Medicine at Mount Sinai
- Study coordinator: Romanoff, Anya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.